跳至主要内容
临床试验/CTRI/2014/02/004425
CTRI/2014/02/004425已完成未知

Randomized, placebo controlled trial of administering oral and vaginal probiotics (VSL#3 and Florisia) in reducing the incidence of recurrent UTI

Indian Council of Medical Research0 个研究点目标入组 176 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
176

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Pre-menopausal women aged 18-45 years
  • 2. History of three or more uncomplicated UTIs diagnosed in the past year, or two uncomplicated UTIs diagnosed in the past six months
  • 3. Sterile urine culture at baseline
  • 4. Agree for completion of screening procedures and agree to return for the subsequent follow up visits
  • 5. Willing to insert vaginal tablet without an applicator
  • 6. Capable of providing informed consent
  • 7. Agree to abstain from self-medication with antibiotics for the UTI symptoms
  • 8. Agree to abstain from antibiotic prophylaxis for recurrent UTI
  • 9. Agree to abstain from the use of any other intra-vaginal product
  • 10. Agree to abstain from sexual intercourse during 8 days course of vaginal tablet

排除标准

  • 1. All pregnant and lactating females
  • 2. Those suffering from any disease of upper or lower urinary tract including pyelonephritis and UTI due to drug resistant strain
  • 3. Patient with history of relapse of UTI within 2 wks, prior to starting the enrollment
  • 4. Symptomatic bacterial vaginosis
  • 5. Patients with immune-compromised status due to diseases like Diabetes/ AIDS

研究者

相似试验